drugset / Trial / NCT01681524

Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI

NCT01681524 ↗

Phase 3 Withdrawn Lantheus Medical Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

The study will evaluate the use of Flurpiridaz F18 injection in patients with CAD to determine if the study drug in PET imaging is better than SPECT imaging currently used for this purpose.

Timeline

Start
2012-11
Primary completion
2014-02
Completion
2014-05

Outcome

Outcome not reported

Stopped: “delayed study start”

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS747158 Diagnostic / imaging agent — —